DGAP-Adhoc: PULSION Medical Systems AG: Preliminary results for 2010; Correction of date of release

PULSION Medical Systems AG  / Key word(s): Miscellaneous

21.03.2011 11:05

Dissemination of a Ad-hoc-correction according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------


Munich, 21 March 2011 - PULSION Medical Systems AG, a medical technology
company listed in the Prime Standard at the Frankfurt Stock Exchange and
specialising in medical diagnosis and therapy systems, announces the
following unaudited results for the financial year 2010 (all values based
on the group financial statements prepared according to IFRS).

Consolidated group revenue in 2010 totalled EUR 31.5 million. This
represented a growth of approx. 12% compared to the previous year's revenue
of EUR 28.1 million.

Gross profits amounted to EUR 20.1 million after EUR 18.6 million in 2009.
The gross margin fell to 63.8%, compared to 66.1% in the previous year. The
operating result (EBIT) stood at EUR 4.6 million following EUR 2.4 million
in the previous year. The EBIT margin thus showed a year-on-year increase
from 8.5% to 14.5%.

Annual net profits rose from EUR 0.5 million (after minority interests) in
2009 to EUR 2.85 million in 2010. The profit per share increased
accordingly from 5 cents to 30 cents.

Free cash flow - defined as cash flow from operating activities, less cash
flow from investments and changes in current assets - rose from EUR 2.3
million to EUR 4.3 million. The EBIT/free cash flow conversion rate was
thus 93%.

Liquid funds as of 31 December 2010 amounted to EUR 4.9 million (incl.
pledged funds) compared to EUR 4.8 million in the previous year (incl.
pledged funds).



Contact:

Investor Relations
PULSION Medical Systems AG 
Ralph Schäfer
Director Legal Affairs 
Tel.: +49 (0)89 / 459914 211 
Fax: +49 (0)89 / 459914 481 
E-mail: schaefer@pulsion.com





21.03.2011 DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      PULSION Medical Systems AG
              Joseph-Wild-Strasse 20
              81829 München
              Deutschland
Phone:        +49 (0)89 4599 14-0
Fax:          +49 (0)89 4599 14-18
E-mail:       info@pulsion.com
Internet:     www.pulsion.com
ISIN:         DE0005487904
WKN:          548790
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------